Notice: This company has been marked as potentially delisted and may not be actively trading. FS Development (FSDC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends FSDC vs. LSEA, GWAC, YSAC, FOLD, VRNA, ZLAB, HCM, ACAD, MOR, and AMRXShould you be buying FS Development stock or one of its competitors? The main competitors of FS Development include Landsea Homes (LSEA), Good Works Acquisition (GWAC), Yellowstone Acquisition (YSAC), Amicus Therapeutics (FOLD), Verona Pharma (VRNA), Zai Lab (ZLAB), HUTCHMED (HCM), ACADIA Pharmaceuticals (ACAD), MorphoSys (MOR), and Amneal Pharmaceuticals (AMRX). FS Development vs. Landsea Homes Good Works Acquisition Yellowstone Acquisition Amicus Therapeutics Verona Pharma Zai Lab HUTCHMED ACADIA Pharmaceuticals MorphoSys Amneal Pharmaceuticals Landsea Homes (NASDAQ:LSEA) and FS Development (NASDAQ:FSDC) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations, community ranking and media sentiment. Does the media prefer LSEA or FSDC? In the previous week, Landsea Homes had 9 more articles in the media than FS Development. MarketBeat recorded 9 mentions for Landsea Homes and 0 mentions for FS Development. Landsea Homes' average media sentiment score of 0.23 beat FS Development's score of 0.00 indicating that Landsea Homes is being referred to more favorably in the media. Company Overall Sentiment Landsea Homes Neutral FS Development Neutral Does the MarketBeat Community favor LSEA or FSDC? Landsea Homes received 21 more outperform votes than FS Development when rated by MarketBeat users. CompanyUnderperformOutperformLandsea HomesOutperform Votes2138.89% Underperform Votes3361.11% FS DevelopmentN/AN/A Is LSEA or FSDC more profitable? Landsea Homes has a net margin of 1.82% compared to FS Development's net margin of 0.00%. Landsea Homes' return on equity of 6.96% beat FS Development's return on equity.Company Net Margins Return on Equity Return on Assets Landsea Homes1.82% 6.96% 2.92% FS Development N/A N/A N/A Do institutionals & insiders have more ownership in LSEA or FSDC? 83.0% of Landsea Homes shares are owned by institutional investors. Comparatively, 89.8% of FS Development shares are owned by institutional investors. 51.0% of Landsea Homes shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has better valuation & earnings, LSEA or FSDC? Landsea Homes has higher revenue and earnings than FS Development. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLandsea Homes$1.21B0.32$29.24M$0.7214.99FS DevelopmentN/AN/AN/AN/AN/A Do analysts recommend LSEA or FSDC? Landsea Homes currently has a consensus target price of $15.50, suggesting a potential upside of 43.65%. Given Landsea Homes' stronger consensus rating and higher probable upside, equities analysts plainly believe Landsea Homes is more favorable than FS Development.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Landsea Homes 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75FS Development 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryLandsea Homes beats FS Development on 11 of the 12 factors compared between the two stocks. Ad True Gold RepublicCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. Get FS Development News Delivered to You Automatically Sign up to receive the latest news and ratings for FSDC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FSDC vs. The Competition Export to ExcelMetricFS DevelopmentPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$789.26M$7.03B$5.37B$8.88BDividend YieldN/A8.03%5.06%4.03%P/E RatioN/A11.50127.4017.46Price / SalesN/A347.551,258.8592.75Price / CashN/A49.2239.3636.42Price / BookN/A9.076.285.86Net IncomeN/A$154.14M$119.59M$225.15M FS Development Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FSDCFS DevelopmentN/A$63.06-0.3%N/A+30.2%$789.26MN/A0.00N/ALSEALandsea Homes4.524 of 5 stars$10.50-5.3%N/A+15.6%$402.38M$1.21B14.58380GWACGood Works AcquisitionN/A$7.43+3.8%N/A+146.6%$159.58MN/A0.002Gap UpHigh Trading VolumeYSACYellowstone AcquisitionN/AN/AN/AN/A$147.38MN/A0.003FOLDAmicus Therapeutics4.6224 of 5 stars$10.49-1.9%N/A+1.0%$3.19B$399.36M-30.85480Analyst ForecastShort Interest ↓VRNAVerona Pharma2.4178 of 5 stars$39.00-2.2%N/A+159.3%$3.19B$460,000.00-20.3130ZLABZai Lab3.2898 of 5 stars$28.96-6.9%N/A+10.8%$3.10B$266.72M-9.462,175News CoverageGap DownHCMHUTCHMED1.7143 of 5 stars$17.48-0.9%N/A-8.0%$3.07B$838M0.001,988Short Interest ↓Gap DownACADACADIA Pharmaceuticals4.1104 of 5 stars$17.93-1.9%N/A-21.5%$3.04B$726.44M22.99510Short Interest ↑Analyst RevisionMORMorphoSys0.0778 of 5 stars$18.96flatN/AN/A$2.86B$238.28M-5.45730AMRXAmneal Pharmaceuticals2.9861 of 5 stars$9.25+0.5%N/A+110.7%$2.85B$2.39B-13.607,700Analyst ForecastShort Interest ↓ Related Companies and Tools Related Companies Landsea Homes Competitors Good Works Acquisition Competitors Yellowstone Acquisition Competitors Amicus Therapeutics Competitors Verona Pharma Competitors Zai Lab Competitors HUTCHMED Competitors ACADIA Pharmaceuticals Competitors MorphoSys Competitors Amneal Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FSDC) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FS Development Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share FS Development With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.